Lancet Microbe最新文献

筛选
英文 中文
The intersection of socioeconomic deprivation and antimicrobial resistance: refocusing on a key determinant.
IF 20.9 1区 生物学
Lancet Microbe Pub Date : 2025-04-02 DOI: 10.1016/j.lanmic.2025.101131
Akaninyene Otu, Vinesh Patel, Stuart Bond, Sarah Chadwick, Bassey Ebenso, Mamoon Aldeyab, Jade Lee-Milner, Victoria Hemming, Kathyrn Deakin, Maria Marcolin
{"title":"The intersection of socioeconomic deprivation and antimicrobial resistance: refocusing on a key determinant.","authors":"Akaninyene Otu, Vinesh Patel, Stuart Bond, Sarah Chadwick, Bassey Ebenso, Mamoon Aldeyab, Jade Lee-Milner, Victoria Hemming, Kathyrn Deakin, Maria Marcolin","doi":"10.1016/j.lanmic.2025.101131","DOIUrl":"https://doi.org/10.1016/j.lanmic.2025.101131","url":null,"abstract":"","PeriodicalId":46633,"journal":{"name":"Lancet Microbe","volume":" ","pages":"101131"},"PeriodicalIF":20.9,"publicationDate":"2025-04-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143789151","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Global surge of Legionnaires' disease in 2024: urgent call for heightened awareness and preparedness 2024年全球军团病激增:紧急呼吁提高认识和防范
IF 20.9 1区 生物学
Lancet Microbe Pub Date : 2025-04-01 DOI: 10.1016/j.lanmic.2024.101031
Ashutosh Pareek , Runjhun Singhal , Aaushi Pareek , Anil Chuturgoon , Ranjit Sah , Vasso Apostolopoulos
{"title":"Global surge of Legionnaires' disease in 2024: urgent call for heightened awareness and preparedness","authors":"Ashutosh Pareek , Runjhun Singhal , Aaushi Pareek , Anil Chuturgoon , Ranjit Sah , Vasso Apostolopoulos","doi":"10.1016/j.lanmic.2024.101031","DOIUrl":"10.1016/j.lanmic.2024.101031","url":null,"abstract":"","PeriodicalId":46633,"journal":{"name":"Lancet Microbe","volume":"6 4","pages":"Article 101031"},"PeriodicalIF":20.9,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142755463","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Vaccine efficacy of NVX-CoV2373 against SARS-CoV-2 infection in adolescents in the USA: an ancillary study to a phase 3, observer-blinded, randomised, placebo-controlled trial NVX-CoV2373 疫苗对美国青少年 SARS-CoV-2 感染的疗效:一项第 3 期观察盲法随机安慰剂对照试验的辅助研究。
IF 20.9 1区 生物学
Lancet Microbe Pub Date : 2025-04-01 DOI: 10.1016/j.lanmic.2024.100984
Meagan E Deming MD PhD , Prof Elizabeth R Brown ScD , Monica A McArthur MD PhD , Stephanie J Schrag DPhil , Melissa Arvay PhD , Mike Humphrys MS , Prof Jacques Ravel PhD , Jeffrey Adelglass MD , Brandon Essink MD , David B Musante MD , Rebecca Maguire MPH , Richard Gorman MD , Elizabeth Formentini MSN MBA , Robin Mason MS MBA , Merlin L Robb MD , Prof Kathleen M Neuzil MD MPH , Rekha R Rapaka MD PhD , Peter Wolff MHA , Prof Karen L Kotloff MD , Michael Waters
{"title":"Vaccine efficacy of NVX-CoV2373 against SARS-CoV-2 infection in adolescents in the USA: an ancillary study to a phase 3, observer-blinded, randomised, placebo-controlled trial","authors":"Meagan E Deming MD PhD , Prof Elizabeth R Brown ScD , Monica A McArthur MD PhD , Stephanie J Schrag DPhil , Melissa Arvay PhD , Mike Humphrys MS , Prof Jacques Ravel PhD , Jeffrey Adelglass MD , Brandon Essink MD , David B Musante MD , Rebecca Maguire MPH , Richard Gorman MD , Elizabeth Formentini MSN MBA , Robin Mason MS MBA , Merlin L Robb MD , Prof Kathleen M Neuzil MD MPH , Rekha R Rapaka MD PhD , Peter Wolff MHA , Prof Karen L Kotloff MD , Michael Waters","doi":"10.1016/j.lanmic.2024.100984","DOIUrl":"10.1016/j.lanmic.2024.100984","url":null,"abstract":"<div><h3>Background</h3><div>Although existing COVID-19 vaccines are known to be highly effective against severe disease and death, data are needed to assess their ability to reduce SARS-CoV-2 infection. We aimed to estimate the efficacy of the NVX-CoV2373 protein subunit vaccine against SARS-CoV-2 infection, regardless of symptoms, among adolescents.</div></div><div><h3>Methods</h3><div>We performed an ancillary observational study (SNIFF) to the phase 3, observer-blinded, randomised, placebo-controlled PREVENT-19 trial that assessed vaccine efficacy against symptomatic COVID-19 in the USA. Participants in the PREVENT-19 trial included healthy adolescents aged 12–17 years and with no history of laboratory-confirmed SARS-CoV-2 infection. They were randomly assigned (2:1) to receive either the NVX-CoV2373 (Novavax, Gaithersburg, MD, USA) vaccine (immediate NVX-CoV2373 group) or placebo (delayed NVX-CoV2373 group) on days 0 and 21 (initial series). After 2 months, in a crossover series, participants received two doses, 21 days apart, of the intervention that they did not receive in their initial series. Participants at 47 of the PREVENT-19 sites were invited to participate in the SNIFF study and self-collect nasal swabs at home twice weekly for SARS-CoV-2 testing to assess vaccine efficacy against SARS-CoV-2 infection. This primary outcome was defined as the first identification of SARS-CoV-2 detected by RT-PCR, regardless of symptoms, with onset within 4 weeks after the second dose of the initial vaccination series until the second dose of the crossover series. Secondary outcomes were vaccine efficacy against asymptomatic and minimally symptomatic SARS-CoV-2 infection, durability of vaccine efficacy against SARS-CoV-2 infection, and durability of vaccine efficacy against asymptomatic and minimally symptomatic infections. Outcomes were analysed in the modified intention-to-treat population, which included all participants without previous SARS-CoV-2 infection and was restricted to participants enrolled within 4 weeks of the second dose of the primary (primary analysis population) or crossover (post-crossover analysis population) series. This study is registered with <span><span>ClinicalTrials.gov</span><svg><path></path></svg></span> (<span><span>NCT04611802</span><svg><path></path></svg></span>).</div></div><div><h3>Findings</h3><div>Between June 1 and Dec 17, 2021, 1196 (53·2%) of the 2247 adolescent participants recruited in the PREVENT-19 trial enrolled in the SNIFF study. The primary analysis population included 471 participants in the immediate NVX-CoV2373 group and 220 in the delayed NVX-CoV2373 group. Incidence of SARS-CoV-2 infection was 14·9 cases per 100 person-years (95% CI 7·9–25·5) in the immediate group and 54·2 cases per 100 person-years (33·6–82·9) in the delayed group; vaccine efficacy was 73·5% (95% CI 47·1–86·7; p=0·0002). Incidence of minimally symptomatic or asymptomatic SARS-CoV-2 infection was 10·3 cases per 100 person-years","PeriodicalId":46633,"journal":{"name":"Lancet Microbe","volume":"6 4","pages":"Article 100984"},"PeriodicalIF":20.9,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143068759","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
WHO world malaria report 2024
IF 20.9 1区 生物学
Lancet Microbe Pub Date : 2025-04-01 DOI: 10.1016/j.lanmic.2025.101073
Priya Venkatesan
{"title":"WHO world malaria report 2024","authors":"Priya Venkatesan","doi":"10.1016/j.lanmic.2025.101073","DOIUrl":"10.1016/j.lanmic.2025.101073","url":null,"abstract":"","PeriodicalId":46633,"journal":{"name":"Lancet Microbe","volume":"6 4","pages":"Article 101073"},"PeriodicalIF":20.9,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143383754","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reassessing the role of butyrate-producing bacteria in infection risk 重新评估丁酸菌在感染风险中的作用。
IF 20.9 1区 生物学
Lancet Microbe Pub Date : 2025-04-01 DOI: 10.1016/j.lanmic.2024.101036
Rajesh Parsanathan
{"title":"Reassessing the role of butyrate-producing bacteria in infection risk","authors":"Rajesh Parsanathan","doi":"10.1016/j.lanmic.2024.101036","DOIUrl":"10.1016/j.lanmic.2024.101036","url":null,"abstract":"","PeriodicalId":46633,"journal":{"name":"Lancet Microbe","volume":"6 4","pages":"Article 101036"},"PeriodicalIF":20.9,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142640068","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Causes, patterns, and epidemiology of tattoo-associated infections since 1820 1820年以来纹身相关感染的原因、模式和流行病学。
IF 20.9 1区 生物学
Lancet Microbe Pub Date : 2025-04-01 DOI: 10.1016/j.lanmic.2024.101006
Sunghyun Yoon PhD , Sandeep Kondakala PhD , Soumana Daddy-Gaoh PhD , Steven Foley PhD , Ohgew Kweon PhD , Seong-Jae Kim PhD
{"title":"Causes, patterns, and epidemiology of tattoo-associated infections since 1820","authors":"Sunghyun Yoon PhD ,&nbsp;Sandeep Kondakala PhD ,&nbsp;Soumana Daddy-Gaoh PhD ,&nbsp;Steven Foley PhD ,&nbsp;Ohgew Kweon PhD ,&nbsp;Seong-Jae Kim PhD","doi":"10.1016/j.lanmic.2024.101006","DOIUrl":"10.1016/j.lanmic.2024.101006","url":null,"abstract":"<div><div>Despite increased awareness and public health initiatives, the incidence of microbial infections related to tattoos has increased since 2000. Building on the first paper in this two-part Series, which detailed the microbiological aspects of tattoo-related infections over the past two centuries from 1820 to 2023, this second paper describes the patterns, causes, and other related epidemiological factors of these infections. Since 2000, bacterial outbreaks, particularly those caused by non-tuberculous mycobacteria, have increased, prompting a re-evaluation of tattoos as a serious public health risk. Insufficient hygiene practices have been the primary cause of microbial infections, with contaminated tattoo inks also contributing substantially, leading to 11 outbreaks and subsequent ink recalls. Although rare, the tattooing process can occasionally lead to life-threatening infections and fatalities. Tattoos by both professional and non-professional artists were associated with infections, suggesting that regulated environments do not necessarily eliminate risk. Additionally, individuals with compromised immune systems, especially those with HIV, were particularly vulnerable to infections such as <em>Leishmania</em>. Although permanent make-up is often perceived as safer than conventional tattoos, infections still occur, with 11 cases reported since 2010. Furthermore, polymicrobial infections involving multiple pathogens have posed challenges for diagnosis and treatment. Overall, these insights highlight the historical and emerging patterns of tattoo-related infections and can inform the development of more effective public health guidelines, enhance preventive measures, and guide future research on reducing the risks associated with tattoos.</div></div>","PeriodicalId":46633,"journal":{"name":"Lancet Microbe","volume":"6 4","pages":"Article 101006"},"PeriodicalIF":20.9,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142819510","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessment of MpoxPlex, a high-throughput and multiplexed immunoassay: a diagnostic accuracy study 评估MpoxPlex,一种高通量和多路免疫分析法:诊断准确性研究。
IF 20.9 1区 生物学
Lancet Microbe Pub Date : 2025-04-01 DOI: 10.1016/j.lanmic.2024.100987
Scott Jones PhD , Bethany Hicks BSc , Helen Callaby MRCP , Daniel Bailey PhD , N Claire Gordon DPhil , Tommy Rampling DPhil , Catherine Houlihan PhD , Rachael Jones FRCP , Marcus Pond PhD , Ravi Mehta MRCP , Deborah Wright PGDip , Clarissa Oeser PhD , Simon Tonge MSc , Ezra Linley PhD , Cathy Rowe MSc , Bassam Hallis PhD , Ashley Otter PhD
{"title":"Assessment of MpoxPlex, a high-throughput and multiplexed immunoassay: a diagnostic accuracy study","authors":"Scott Jones PhD ,&nbsp;Bethany Hicks BSc ,&nbsp;Helen Callaby MRCP ,&nbsp;Daniel Bailey PhD ,&nbsp;N Claire Gordon DPhil ,&nbsp;Tommy Rampling DPhil ,&nbsp;Catherine Houlihan PhD ,&nbsp;Rachael Jones FRCP ,&nbsp;Marcus Pond PhD ,&nbsp;Ravi Mehta MRCP ,&nbsp;Deborah Wright PGDip ,&nbsp;Clarissa Oeser PhD ,&nbsp;Simon Tonge MSc ,&nbsp;Ezra Linley PhD ,&nbsp;Cathy Rowe MSc ,&nbsp;Bassam Hallis PhD ,&nbsp;Ashley Otter PhD","doi":"10.1016/j.lanmic.2024.100987","DOIUrl":"10.1016/j.lanmic.2024.100987","url":null,"abstract":"<div><h3>Background</h3><div>In May, 2022, the first global outbreak of mpox (formerly known as monkeypox) occurred. In response, public health agencies in the UK have made smallpox vaccines available to individuals at the highest risk of infection. With mpox cases still being detected globally, novel tools are required to aid with diagnosis, serosurveillance, and the evaluation of immune responses following infection and immunisation with current and new vaccine candidates. Here, we describe the development of a multiplexed immunoassay, MpoxPlex, able to measure IgG responses to 12 <em>Orthopoxvirus</em> antigens concurrently and distinguish between responses to infection and vaccination.</div></div><div><h3>Methods</h3><div>Using the Luminex (DiaSorin, Saluggia, Italy) platform, antibody responses to vaccinia virus (VACV) antigens B5, A27, and A33 and monkeypox virus (MPXV) antigens E8, B6, B2, M1, A27, A35, H3, A29, and A5 were assessed in serum from individuals after MPXV infection (n=24) and after vaccination (n=75) with modified VACV Ankara-Bavarian Nordic. Assay characteristics and cutoffs were calculated by fitting receiver operating characteristic curves to the median fluorescence intensities of these positive samples and negative samples that were run alongside (n=435). P values were calculated using non-parametric Mann–Whitney, Kruskal–Wallis, and Dunn’s multiple comparisons tests.</div></div><div><h3>Findings</h3><div>Using the results from a combination of eight antigens, we were able to distinguish samples as either post-vaccination or post-infection from negative samples with a sensitivity of 98% and a specificity of 95%. IgG responses to MPXV antigen A27 were able to distinguish post-MPXV infection with a sensitivity of 88% and a specificity of 97%. VACV antigen A27 and MPXV antigens A29 and A5 provided little diagnostic advantage.</div></div><div><h3>Interpretation</h3><div>With additional benefits over current serological assays, we believe this assay will provide substantial insight into the current global outbreak of mpox. MpoxPlex shows use for both serosurveillance and immunological studies of vaccination and infection.</div></div><div><h3>Funding</h3><div>Grant-in-aid funding to the Emerging Pathogen Serology Group at Porton Down, UK Health Security Agency.</div></div>","PeriodicalId":46633,"journal":{"name":"Lancet Microbe","volume":"6 4","pages":"Article 100987"},"PeriodicalIF":20.9,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143013605","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tracking pandemic pathogens from wastewater surveillance in international airports: Klebsiella pneumoniae ST16 coproducing NDM-4 and OXA-181 arriving in South America
IF 20.9 1区 生物学
Lancet Microbe Pub Date : 2025-04-01 DOI: 10.1016/j.lanmic.2024.101071
Rubens R Sousa-Carmo , Johana Becerra , Elder Sano , Herrison Fontana , Thais Martins-Gonçalves , Gustavo Queiroga , Bruna Fuga , Renan L O Silva , Mikaela R F Barbosa , Maria Inês Z Sato , Nilton Lincopan
{"title":"Tracking pandemic pathogens from wastewater surveillance in international airports: Klebsiella pneumoniae ST16 coproducing NDM-4 and OXA-181 arriving in South America","authors":"Rubens R Sousa-Carmo ,&nbsp;Johana Becerra ,&nbsp;Elder Sano ,&nbsp;Herrison Fontana ,&nbsp;Thais Martins-Gonçalves ,&nbsp;Gustavo Queiroga ,&nbsp;Bruna Fuga ,&nbsp;Renan L O Silva ,&nbsp;Mikaela R F Barbosa ,&nbsp;Maria Inês Z Sato ,&nbsp;Nilton Lincopan","doi":"10.1016/j.lanmic.2024.101071","DOIUrl":"10.1016/j.lanmic.2024.101071","url":null,"abstract":"","PeriodicalId":46633,"journal":{"name":"Lancet Microbe","volume":"6 4","pages":"Article 101071"},"PeriodicalIF":20.9,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143374647","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Crucial analysis of Nef-mediated MHC-I modulation in the maintenance of the HIV-1 reservoir.
IF 20.9 1区 生物学
Lancet Microbe Pub Date : 2025-04-01 DOI: 10.1016/j.lanmic.2025.101133
Xinyue Wang, Yaxian Kong
{"title":"Crucial analysis of Nef-mediated MHC-I modulation in the maintenance of the HIV-1 reservoir.","authors":"Xinyue Wang, Yaxian Kong","doi":"10.1016/j.lanmic.2025.101133","DOIUrl":"https://doi.org/10.1016/j.lanmic.2025.101133","url":null,"abstract":"","PeriodicalId":46633,"journal":{"name":"Lancet Microbe","volume":" ","pages":"101133"},"PeriodicalIF":20.9,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143789149","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Novel human-type receptor-binding H5N1 virus in live poultry markets, China 中国活禽市场的新型人型受体结合型H5N1病毒。
IF 20.9 1区 生物学
Lancet Microbe Pub Date : 2025-04-01 DOI: 10.1016/j.lanmic.2024.101049
Feng Wen , Yu Yang , Yong Li , Jinyue Guo , Zhili Li , Lian Liu , Hao Liu , Kun Mei , Limei Qin , Keshan Zhang , Tao Ren , Shujian Huang
{"title":"Novel human-type receptor-binding H5N1 virus in live poultry markets, China","authors":"Feng Wen ,&nbsp;Yu Yang ,&nbsp;Yong Li ,&nbsp;Jinyue Guo ,&nbsp;Zhili Li ,&nbsp;Lian Liu ,&nbsp;Hao Liu ,&nbsp;Kun Mei ,&nbsp;Limei Qin ,&nbsp;Keshan Zhang ,&nbsp;Tao Ren ,&nbsp;Shujian Huang","doi":"10.1016/j.lanmic.2024.101049","DOIUrl":"10.1016/j.lanmic.2024.101049","url":null,"abstract":"","PeriodicalId":46633,"journal":{"name":"Lancet Microbe","volume":"6 4","pages":"Article 101049"},"PeriodicalIF":20.9,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142822768","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信